BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 17892861)

  • 1. Association of a CXCL9 polymorphism with pediatric Crohn's disease.
    Lacher M; Kappler R; Berkholz S; Baurecht H; von Schweinitz D; Koletzko S
    Biochem Biophys Res Commun; 2007 Nov; 363(3):701-7. PubMed ID: 17892861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
    Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
    Latiano A; Palmieri O; Valvano MR; D'Incà R; Caprilli R; Cucchiara S; Sturniolo GC; Bossa F; Andriulli A; Annese V
    Aliment Pharmacol Ther; 2008 Feb; 27(3):241-8. PubMed ID: 17944996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-1 receptor antagonist (IL-1Ra) gene polymorphism in patients with inflammatory bowel disease in India.
    Mittal RD; Bid HK; Ghoshal UC
    Scand J Gastroenterol; 2005 Jul; 40(7):827-31. PubMed ID: 16109659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 14-bp deletion polymorphism in the HLA-G gene displays significant differences between ulcerative colitis and Crohn's disease and is associated with ileocecal resection in Crohn's disease.
    Glas J; Török HP; Tonenchi L; Wetzke M; Beynon V; Teshome MY; Cotofana S; Schiemann U; Griga T; Klein W; Epplen JT; Folwaczny C; Folwaczny M; Mussack T; Weiss EH
    Int Immunol; 2007 May; 19(5):621-6. PubMed ID: 17446213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population.
    Glas J; Konrad A; Schmechel S; Dambacher J; Seiderer J; Schroff F; Wetzke M; Roeske D; Török HP; Tonenchi L; Pfennig S; Haller D; Griga T; Klein W; Epplen JT; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Mussack T; Folwaczny M; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2008 Mar; 103(3):682-91. PubMed ID: 18162085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism in ICAM-1, PECAM-1, E-selectin, and L-selectin genes in Tunisian patients with inflammatory bowel disease.
    Khazen D; Jendoubi-Ayed S; Aleya WB; Sfar I; Mouelhi L; Matri S; Najjar T; Filali A; Gorgi Y; Abdallah TB; Ayed K
    Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):167-75. PubMed ID: 19212205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mannan-binding lectin (MBL) gene polymorphisms in ulcerative colitis and Crohn's disease.
    Rector A; Lemey P; Laffut W; Keyaerts E; Struyf F; Wollants E; Vermeire S; Rutgeerts P; Van Ranst M
    Genes Immun; 2001 Oct; 2(6):323-8. PubMed ID: 11607788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
    Cantor MJ; Nickerson P; Bernstein CN
    Am J Gastroenterol; 2005 May; 100(5):1134-42. PubMed ID: 15842590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contribution of OCTN1/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn's disease.
    Noble CL; Nimmo ER; Drummond H; Ho GT; Tenesa A; Smith L; Anderson N; Arnott ID; Satsangi J
    Gastroenterology; 2005 Dec; 129(6):1854-64. PubMed ID: 16344054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases.
    Weersma RK; Oostenbrug LE; Nolte IM; Van Der Steege G; Oosterom E; Van Dullemen HM; Kleibeuker JH; Dijkstra G
    Scand J Gastroenterol; 2007 Jul; 42(7):827-33. PubMed ID: 17558906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms of tumor necrosis factor-alpha but not MDR1 influence response to medical therapy in pediatric-onset inflammatory bowel disease.
    Cucchiara S; Latiano A; Palmieri O; Canani RB; D'Incà R; Guariso G; Vieni G; De Venuto D; Riegler G; De'Angelis GL; Guagnozzi D; Bascietto C; Miele E; Valvano MR; Bossa F; Annese V;
    J Pediatr Gastroenterol Nutr; 2007 Feb; 44(2):171-9. PubMed ID: 17255827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A NFKB1 promoter polymorphism is involved in susceptibility to ulcerative colitis.
    Borm ME; van Bodegraven AA; Mulder CJ; Kraal G; Bouma G
    Int J Immunogenet; 2005 Dec; 32(6):401-5. PubMed ID: 16313306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of interleukin-17F 7488 single nucleotide polymorphism and inflammatory bowel disease in the Chinese population.
    Chen B; Zeng Z; Hou J; Chen M; Gao X; Hu P
    Scand J Gastroenterol; 2009; 44(6):720-6. PubMed ID: 19263269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF-857 polymorphism in Israeli Jewish patients with inflammatory bowel disease.
    Fidder HH; Heijmans R; Chowers Y; Bar-Meir S; Avidan B; Pena AS; Crusius JB
    Int J Immunogenet; 2006 Apr; 33(2):81-5. PubMed ID: 16611251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The -A2518G polymorphism of monocyte chemoattractant protein-1 is associated with Crohn's disease.
    Palmieri O; Latiano A; Salvatori E; Valvano MR; Bossa F; Latiano T; Corritore G; di Mauro L; Andriulli A; Annesec V
    Am J Gastroenterol; 2010 Jul; 105(7):1586-94. PubMed ID: 20125127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The functional genetic variation in the PTPN22 gene has a negligible effect on the susceptibility to develop inflammatory bowel disease.
    Martín MC; Oliver J; Urcelay E; Orozco G; Gómez-Garcia M; López-Nevot MA; Piñero A; Brieva JA; de la Concha EG; Nieto A; Martín J
    Tissue Antigens; 2005 Oct; 66(4):314-7. PubMed ID: 16185327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT4 gene influences genetic predisposition to ulcerative colitis but not Crohn's disease in the Spanish population: a replication study.
    Diaz-Gallo LM; Palomino-Morales RJ; Gómez-García M; Cardeña C; Rodrigo L; Nieto A; Alcain G; Cueto I; López-Nevot MA; Martin J
    Hum Immunol; 2010 May; 71(5):515-9. PubMed ID: 20153791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inducible and endothelial nitric oxide synthase genes polymorphism in inflammatory bowel disease.
    Oliver J; Gómez-Garcia M; Vilchez JR; López-Nevot MA; Piñero A; Correro F; Nieto A; Martín J
    Tissue Antigens; 2006 Apr; 67(4):326-30. PubMed ID: 16634870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions among genes influencing bacterial recognition increase IBD risk in a population-based New Zealand cohort.
    Petermann I; Huebner C; Browning BL; Gearry RB; Barclay ML; Kennedy M; Roberts R; Shelling AN; Philpott M; Han DY; Ferguson LR
    Hum Immunol; 2009 Jun; 70(6):440-6. PubMed ID: 19275920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.